BP PLC (BP)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 612.70 |
|---|---|
| 52-week range | 413.30 – 638.50 |
| Return, 1 month / 3 months | +9.7% / +14.7% |
| Return, 1 year / 3 years | +40.6% / +15.7% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 31.6% |
| Worst drawdown (1 year) | -24.8% |
| Average daily value traded | 26,739.72M GBX |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BP is an energy company based in London that explores for and produces oil and natural gas, refines crude oil, and markets fuels and lubricants. It serves retail drivers through its network of petrol stations and supplies aviation, marine and industrial customers with fuels and related products. The company also produces lubricants and petrochemicals, and its operations span many countries across Europe, the Americas, Asia and Africa.
On this site BP PLC appears as a stock on the London Stock Exchange (UK), code BP, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BP PLC (BP) trades on the London Stock Exchange in UK. It last closed at GBX 612.70 on 27 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 209 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.6% and over the last three months it rose 14.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.5% | ||
| From 52-week high | -4.0% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.7% | ||
| 6-month return | 7.1% | ||
| 12-month return, skipping the last month | 28.2% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.8% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 26,739.72M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 76 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +9.7% |
| 3 months | +14.7% |
| 6 months | +7.1% |
| 1 year | +40.6% |
| 3 years | +15.7% |
| 5 years | +71.8% |
Signals
| 50-day / 200-day average | 567.11 / 530.32 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 16.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.0641 |
| 14 May 2026 | GBP 0.0617 |
| 19 Feb 2026 | GBP 0.0623 |
| 13 Nov 2025 | GBP 0.0624 |
| 14 Aug 2025 | GBP 0.0619 |
| 15 May 2025 | GBP 0.0590 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.